Veeva Summit: Bringing Together Experts to Discuss AI in Life Sciences and Commercial Excellence

Veeva Summit: Pioneering AI Innovations in Life Sciences Industry

The upcoming Veeva Commercial Summit in Copenhagen on November 18-19, 2026, is set to showcase the forefront of innovation in the life sciences sector. With over 1,200 industry leaders, including executives from renowned companies like AstraZeneca, Bristol Myers Squibb, and Roche, the summit aims to delve into the transformative role of AI in enhancing customer engagement and commercial strategies.

At this year's event, attendees will discuss a variety of pioneering strategies that harness advanced AI technologies to bolster marketing, sales, and medical teams across the industry. Veeva Systems, the organizing body, highlights how these innovations will improve customer interactions, streamline content delivery, and ultimately enhance treatment outcomes. The summit will provide platforms for over 100 engaging sessions focused on customer success stories and AI advancements utilizing Veeva's Commercial Cloud and Data Cloud technologies.

Among the key topics to be addressed are:
1. Agentic Commercial Capabilities: Key players like Grünenthal and Roche will present on how they are leveraging AI to create connected healthcare professional (HCP) journeys that seamlessly integrate field, digital, and event interactions.
2. Enhanced HCP Experiences: Companies such as GSK are set to discuss their efforts in utilizing agentic customer relationship management (CRM) systems to deliver a more personalized experience for HCPs.
3. Insights from Conversational AI: BeOne Medicines will share insights on how conversational AI is being used to identify and address treatment barriers faced by patients and healthcare professionals.
4. Efficiency in Content Approvals: Bristol Myers Squibb will showcase their strategies for expediting promotional content approvals, thereby enhancing productivity with agentic medical, legal, and regulatory (MLR) reviews.
5. Data Foundations for AI: AstraZeneca will discuss how access to HCP data can refine sales targeting strategies, driving growth in their operations.
6. Global Data Foundations: Companies like Bayer and Servier will address how building a robust global data foundation is crucial for scaling AI and improving decision-making.
7. Maximizing Medical Impact: Biogen, UCB, and other leading biopharmas will explain how they are translating medical insights into concrete actions aimed at improving patient outcomes.
8. Evolution of Scientific Engagement: Bayer, Novo, and One MSL will explore how the growing integration of AI by HCPs is reshaping their engagement with scientific content.

Chris Moore, the President of Veeva Europe, emphasized the urgent need for innovation in the life sciences sector, stating, "The pace of innovation across life sciences is accelerating, with AI creating new opportunities for more meaningful, timely engagement with HCPs and patients." The Veeva Summit not only promises to foster collaboration and sharing of best practices but also aims to push the industry closer towards an agentic commercial model that emphasizes adaptability and responsiveness.

The Veeva Summit is designed exclusively for life sciences professionals, reinforcing its commitment to industry-specific advancements. Interested participants can register at veeva.com/eu/Summit and join a dynamic dialogue aimed at shaping the future of life sciences with AI.

About Veeva Systems

Veeva Systems is recognized as a leader in providing cloud solutions specifically tailored for the life sciences industry. With a commitment to innovation and customer success, Veeva supports a diverse client base ranging from some of the largest pharmaceutical companies to emerging biotech firms. As a Public Benefit Corporation, Veeva endeavors to balance the interests of all stakeholders including customers, employees, and shareholders, making significant contributions to the industry's progress.

With the advancements and discussions set to unfold at the Veeva Commercial Summit, participants are poised for a transformative experience that highlights the effective utilization of AI within the realm of life sciences.